Minnnesota Bioscience Jobs

Job Information

Pfizer, Inc. Director, Field Medical, Gastroenterology MD in Minneapolis, Minnesota

There are 11 open positions covering different territories across the US. ROLE SUMMARY: The Director, Field Medical, Gastroenterology is a field-based medical colleague in the Field Medical Director (FMD) group who is responsible for providing therapeutic area /product expertise for Gastroenterology in the assigned region (comprised of one or more US states) focusing on the therapeutic area's in-line and late-stage portfolio including Xeljanz and Inflectra. The US I and I Xeljanz and Inflectra FMD Team is expanding due to the FDA approval of a fourth indication for Xeljanz in September 2020 with a fifth indication expected in 2021. In response, the Xeljanz and Inflectra FMD Teams will be divided into three FMD Teams that support US Rheumatology HCPs for the Rheumatology indications and two new FMD Teams that support US Gastroenterology HCPs for the Gastroenterology indications. The responsibilities of the Director, Field Medical, Gastroenterology are to contribute to Pfizer's ability to (a) communicate new and other important approved medical content related to the safe and appropriate use of Pfizer medicines to Gastroenterology health care professionals (HCPs) in local, regional or national capacities including therapeutic area HCP decision-makers at organized customers such as Medical Groups, Integrated Delivery Networks, Payers, etc. and engage in other approved communications in accordance with approved FMD guidance; (b) provide truthful, accurate and scientifically supported information in response to direct unsolicited medical requests from HCPs in a manner that complies with all applicable Pfizer guidelines, policies, and procedures; and (c) provide therapeutic area/product expertise for regional and other Medical Affairs and/or clinical development needs as approved by FMD leadership (e.g. formulary presentations, field force training, organized customer projects/collaborations, scientific congress participation, Pfizer-sponsored research site / investigator interactions, TA/product expertise for Pfizer-sponsored NIS, IIR inquiries etc.). The Director, Field Medical, Gastroenterology will interact with HCPs in the region including Gastroenterology HCPs affiliated with organized customers. The FMD will respond to medical questions regarding Pfizer products for the designated therapeutic area including Xeljanz and Inflectra and other Pfizer medicines as appropriate. The FMD may be involved in presentations to payers, managed care organizations, formulary decision makers and regional medical advisory boards in accordance with the designated therapeutic area medical strategy established by the FMD TL. The FMD will also facilitate communication between regional and national HCPs and headquarters Medical Affairs colleagues and provide customer insights that contribute to the development of brand medical strategies as appropriate. The FMD will facilitate both Pfizer sponsored and investigator initiated research activities in their regions, as determined by the HQ Medical teams and in accordance with guidance. The Director Field Medical, Gastroenterology, MD/DO will represent Pfizer Medical Affairs with external MD-based professional associations and/or societies and contribute expertise and insights to brand and other cross-functional workstreams as a trained physician ROLE RESPONSIBILITIES: The FMD will primarily be responsible for providing approved medical content on Pfizer's products in Gastroenterology including Xeljanz and Inflectra to HCPs who have local, regional, or national roles in health care provision and/or decision-making as determined by Pfizer, the I and I FMD Group Lead, FMD TL, and US Medical Affairs. Keep abreast of medical and scientific developments in the designated therapeutic area by continuously reviewing literature in the field, monitoring competitor activities, networking with experts and attending assigned conferences. Maintain effective and appropriate communication and collaboration am